sn.at – Date: 01.06.2024
Author: Iris Burtscher, sn.at – Source
After a year of focusing on PCR tests during the pandemic, Novogenia is returning to its core business of genetic analysis and personalized supplements. The company, which became a major player in PCR testing, has now completed its last COVID-19 test. Moving forward, Novogenia is investing heavily in expanding its genetic analysis services and personalized product offerings.
